Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.
A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals.
[Position of darunavir in antiretroviral therapy].
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.
Fumarate and nitrate reduction (FNR) dependent activation of the Escherichia coli anaerobic ribonucleotide reductase nrdDG promoter.
Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.
The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication.
HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells.
Immune-driven recombination and loss of control after HIV superinfection.
HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.